AGING - High-Impact Journal on Aging Research
In 2008 the Ongoing Revolution in aging research has called for a High-Impact Journal. By now Aging journal has become one of the leading journals in the field.
Aging primarily publishes papers of outstanding significance, exceptional novelty, and ground-breaking discoveries in all disciplines from yeast to humans and from evolution to medicine. Aging covers (in addition to traditional topics on aging) many other topics including cellular and molecular biology (regulation of translation, cell growth, death and autophagy, mitochondria, DNA damage and repair, microRNAs, stem cells), human age-related diseases, pathology in model organisms, cancer and first of all signal transduction pathways (p53, sirtuins, PI-3K/AKT/mTOR and so on) and approaches to modulate these signaling pathways.
Aging is abbreviated by indexes: by PubMed - Aging (Albany NY); by ISI/Thomson - Aging-US; by Scopus - Aging.
Aging Impact Factor (IF) /ISI/ Web of Science (Thomson Reuters JCR:
The highest impact factor in the field
Scopus: Ranks Q1
November 13-16, 2016: ASMB 2016 Biennial Meeting
September 25-28, 2016:
Aging is proud to support the Cell Fate Diversity in Aging Conference, Croatia
September 21-22, 2016:
Aging is a Conference Sponsor of Aging and Drug Discovery, Basel, Switzerland
April 25-28, 2016: Biomedical Innovation in Healthy Longevity. Saint-Petersburg. Russia http://ivaoconf.com. Aging is honored that many speakers have published their research in the journal. A special gift was prepared for the speakers: a printed booklet with their papers published in Aging.
Elizabeth Blackburn, a member of the Editorial Board of AGING, won the Nobel Prize in Physiology or Medicine 2009. Elizabeth Blackburn co-authored a paper published in the first (inaugural) issue of Aging.